From public IRS filings
Cholangiocarcinoma Foundation
SALT LAKE CITY, UT · Medical Research
Built from IRS filings (latest Form 990: tax year 2023). Cholangiocarcinoma Foundation has not reviewed or approved this page. Kindora is not affiliated with it.
Not yet reviewed by the organization · built from public records, so it may contain inaccuraciesIs this your organization? Review this page.Ask us to hide this profileHow this works
Mission
THE ORGANIZATION'S MISSION IS TO FIND A CURE AND IMPROVE THE QUALITY OF LIFE FOR CHOLANGIOCARCINOMA PATIENTS.
Financials (IRS Form 990)
Total revenue
$6.9M
Total expenses
$6.2M
Total assets
$6M
Program expense ratio
75%
Source: IRS Form 990, tax year 2023.
Who funds Cholangiocarcinoma Foundation
$5M in foundation grants on record from 86 funders — matched from IRS 990 grant line items. Some matches may be approximate.
| Funder | Total given | Grants |
|---|---|---|
| Fidelity Investments Charitable Gift Fund | $1.2M | 4 |
| American Endowment Foundation | $765K | 3 |
| Vanguard Charitable Endowment Program | $605K | 4 |
| Morgan Stanley Global Impact Funding Trust | $565K | 3 |
| American Online Giving Foundation | $294K | 5 |
| Gidel Family Foundation | $261K | 2 |
| Paypal Charitable Giving Fund | $234K | 3 |
| National Philanthropic Trust | $225K | 4 |
| Donor Advised Charitable Giving | $159K | 4 |
| Global Coalition for Adaptive Research | $150K | 1 |
Leadership
STACIE LINDSEY — CFO (Principal officer)
Names of officers and trustees come from the organization's public filings and leave this page when a later filing drops them. If you are named here and object, write to privacy@kindora.co.